Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review | NITAG RESOURCE CENTER

Rating:

Critically low

Authors:

Parker, E. P. K.

Desai, S.

Marti, M.

Nohynek, H.

Kaslow, D. C.

Kochhar, S.

O'Brien, K. L.

Hombach, J.

Wilder-Smith, A.

Disease:

COVID-19

Methodological quality (AMSTAR 2):

Critically low

Source(s):

https://doi.org/10.1016/S2214-109X(21)00593-3

Open access:

Yes

Date of last literature search:

Sep 2021

Number of studies:

23

Publication year:

2022

Abstract

Adults
Older adults
COVID-19
Safety
Efficacy/effectiveness